SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.31), $0.08 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $11.7 million versus the consensus estimate of $12.15 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.